Creo Medical Group PLC (CREO) — Net Asset Quality Index
Creo Medical Group PLC (CREO) has a Net Asset Quality Index of 84.6% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX59.10 Million minus total liabilities of GBX9.10 Million yields net assets of GBX50.00 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Creo Medical Group PLC (CREO) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Creo Medical Group PLC Net Asset Quality Index Over Time (2005–2025)
This chart shows how Creo Medical Group PLC's Net Asset Quality Index has evolved across 18 annual periods from 2005 to 2025. As of December 2025, the index stands at 84.6%, representing net assets of GBX50.00 Million against total assets of GBX59.10 Million GBX. For live market cap and overall valuation, see Creo Medical Group PLC (CREO) market capitalisation.
Annual Net Asset Quality Index for Creo Medical Group PLC (2005–2025)
The table below presents the year-by-year Net Asset Quality Index for Creo Medical Group PLC from 2005 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check how strategically is Creo Medical Group PLC's equity deployed to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.6% | GBX50.00 Million | GBX59.10 Million | GBX9.10 Million | ▲ +19.4 pp |
| 2024 | 65.2% | GBX42.40 Million | GBX65.00 Million | GBX22.60 Million | ▼ -12.8 pp |
| 2023 | 78.1% | GBX59.80 Million | GBX76.60 Million | GBX16.80 Million | ▲ +12.5 pp |
| 2022 | 65.6% | GBX49.40 Million | GBX75.34 Million | GBX25.93 Million | ▼ -7.3 pp |
| 2021 | 72.9% | GBX73.32 Million | GBX100.61 Million | GBX27.29 Million | ▲ +4.9 pp |
| 2020 | 67.9% | GBX62.81 Million | GBX92.46 Million | GBX29.66 Million | ▼ -25.7 pp |
| 2019 | 93.7% | GBX82.66 Million | GBX88.26 Million | GBX5.60 Million | ▼ -2.3 pp |
| 2018 | 95.9% | GBX47.71 Million | GBX49.75 Million | GBX2.03 Million | ▲ +19.7 pp |
| 2018 | 76.2% | GBX7.33 Million | GBX9.62 Million | GBX2.29 Million | ▼ -14.7 pp |
| 2017 | 90.9% | GBX14.65 Million | GBX16.12 Million | GBX1.47 Million | ▲ +23.5 pp |
| 2016 | 67.4% | GBX1.63 Million | GBX2.42 Million | GBX788.81K | ▼ -18.4 pp |
| 2016 | 85.8% | GBX3.22 Million | GBX3.75 Million | GBX532.79K | ▲ +14.2 pp |
| 2015 | 71.7% | GBX748.41K | GBX1.04 Million | GBX295.98K | ▼ -12.9 pp |
| 2014 | 84.6% | GBX1.37 Million | GBX1.62 Million | GBX250.20K | ▲ +18.5 pp |
| 2008 | 66.1% | GBX113.00K | GBX171.00K | GBX58.00K | ▲ +61.4 pp |
| 2007 | 4.7% | GBX12.00K | GBX257.00K | GBX245.00K | ▲ +6.5 pp |
| 2006 | -1.9% | GBX-3.00K | GBX161.00K | GBX164.00K | ▲ +238.1 pp |
| 2005 | -240.0% | GBX-12.00K | GBX5.00K | GBX17.00K | — |